iMD Companies, Inc. (ICBU)
USD 0.0
(-4.44%)
USD 0.0
(-4.44%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -154.65 Thousand USD | 42.75% |
| 2022 | -268.59 Thousand USD | -135.95% |
| 2021 | -118.31 Thousand USD | -491.79% |
| 2020 | -18.99 Thousand USD | -19.96% |
| 2019 | -17.03 Thousand USD | 92.87% |
| 2018 | -224.91 Thousand USD | -107.12% |
| 2017 | 3.11 Million USD | 99.05% |
| 2016 | 1.56 Million USD | 633.37% |
| 2015 | -787.06 Thousand USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -49.89 Thousand USD | 5.07% |
| 2024 Q1 | -52.78 Thousand USD | -14.17% |
| 2023 FY | - USD | 42.75% |
| 2023 Q3 | -21.27 Thousand USD | -16.55% |
| 2023 Q1 | -64.1 Thousand USD | -50.86% |
| 2023 Q2 | -18.25 Thousand USD | 71.53% |
| 2023 Q4 | -47.57 Thousand USD | -123.65% |
| 2022 Q2 | -88.88 Thousand USD | 24.33% |
| 2022 FY | - USD | -135.95% |
| 2022 Q3 | -16.33 Thousand USD | 81.63% |
| 2022 Q4 | -42.49 Thousand USD | -160.2% |
| 2022 Q1 | -117.46 Thousand USD | -1131.24% |
| 2021 Q2 | -27.36 Thousand USD | -22.31% |
| 2021 Q4 | -9540.00 USD | 82.04% |
| 2021 Q3 | -53.11 Thousand USD | -94.12% |
| 2021 FY | - USD | -491.79% |
| 2021 Q1 | -22.37 Thousand USD | 0.0% |
| 2020 FY | - USD | -19.96% |
| 2019 FY | - USD | 92.87% |
| 2018 FY | - USD | -107.12% |
| 2017 FY | - USD | 99.05% |
| 2016 FY | - USD | 633.37% |
| 2015 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| American Bio Medica Corporation | -1.16 Million USD | 86.702% |
| Arrayit Corporation | -3.07 Million USD | 94.975% |
| Atlantic International Corp. | -5.38 Million USD | 97.13% |
| Biocept, Inc. | -30.24 Million USD | 99.489% |
| Bioqual, Inc. | 3.03 Million USD | 105.1% |
| CardioGenics Holdings Inc | -757.37 Thousand USD | 79.58% |
| DermTech, Inc. | -97.89 Million USD | 99.842% |
| Global WholeHealth Partners Corporation | - USD | Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 2.91 Billion USD | 100.005% |
| HTG Molecular Diagnostics, Inc. | -20.24 Million USD | 99.236% |
| IDenta Corp. | 71.58 Thousand USD | 316.043% |
| Interpace Biosciences, Inc. | 3.83 Million USD | 104.031% |
| Integrative Health Technologies, Inc. | 38.69 Thousand USD | 499.739% |
| InVitro International | 6680.00 USD | 2415.254% |
| Lumos Diagnostics Holdings Limited | -5.43 Million USD | 97.155% |
| Many Bright Ideas Technologies Inc. | -12.13 Thousand USD | -1174.592% |
| Medical Imaging Corp. | -896.74 Thousand USD | 82.753% |
| NovelStem International Corp. | -3.78 Million USD | 95.915% |
| Optigenex Inc. | -1.18 Million USD | 86.968% |
| PharmChem, Inc. | 1.05 Million USD | 114.676% |
| Proteome Sciences plc | -1.13 Million USD | 86.398% |
| Response Genetics, Inc | -19.66 Million USD | 99.214% |
| Rennova Health, Inc. | -234.81 Thousand USD | 34.136% |
| RushNet, Inc. | -614.85 Thousand USD | 74.846% |
| ScreenPro Security Inc. | -3.43 Million USD | 95.497% |
| Stella Diagnostics Inc. | -5.7 Million USD | 97.29% |
| StageZero Life Sciences Ltd. | -10.27 Million USD | 98.494% |
| Todos Medical Ltd. | -9.39 Million USD | 98.354% |